INOZYME PHARMA INC's ticker is INZY and the CUSIP is 45790W108. A total of 40 filers reported holding INOZYME PHARMA INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $286,020 | -40.0% | 68,100 | -20.4% | 0.00% | 0.0% |
| Q2 2023 | $476,720 | +27.0% | 85,587 | +30.7% | 0.00% | 0.0% |
| Q1 2023 | $375,315 | +2786.6% | 65,500 | +429.0% | 0.00% | – |
| Q4 2022 | $13,002 | -62.9% | 12,383 | -6.1% | 0.00% | – |
| Q3 2022 | $35,000 | -22.2% | 13,183 | +20.8% | 0.00% | – |
| Q1 2022 | $45,000 | – | 10,916 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pivotal bioVenture Partners Investment Advisor LLC | 3,661,518 | $20,394,655 | 6.72% |
| CHI Advisors LLC | 1,195,027 | $6,656,301 | 2.02% |
| Affinity Asset Advisors, LLC | 751,796 | $4,187,504 | 1.46% |
| Sofinnova Investments, Inc. | 3,655,308 | $20,360,066 | 1.33% |
| NEA Management Company, LLC | 2,437,689 | $13,577,928 | 1.04% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,131,967 | $6,305,056 | 0.98% |
| Knott David M Jr | 220,000 | $1,225 | 0.49% |
| Rock Springs Capital Management LP | 3,428,084 | $19,094,428 | 0.45% |
| Deep Track Capital, LP | 1,644,021 | $9,157,197 | 0.42% |
| MPM BioImpact LLC | 326,921 | $1,820,950 | 0.37% |